Cyanocobalamin vs Methylcobalamin: The Real Difference

Search “cyanocobalamin vs methylcobalamin” and most of what comes back is a verdict. One form is natural, the other is synthetic, pick the natural one. That framing is popular because it is short, and it skips the part of the chemistry that actually explains why manufactured B12 looks the way it does.

The honest version is more specific and more useful. Vitamin B12 is not one molecule. It is a family of molecules that differ by a single attached group, all four of which converge on the same two coenzymes inside the cell. What separates them commercially is stability, cost, and shelf life - not activity.

This is a chemistry explainer. It contains no dosing information, no guidance on deficiency, and no administration instructions. WWP supplies B12 for laboratory and research use only.

B12 is not one molecule

Cobalamin is the largest and most structurally complex of the vitamins, and the only one that contains a metal ion. At its center is a cobalt atom held inside a corrin ring, a nitrogen-containing macrocycle related to the porphyrin ring in heme but with one fewer bridging carbon.

The cobalt has two axial positions, above and below the ring plane. The lower position is occupied by a dimethylbenzimidazole group that is part of the molecule’s own structure. The upper position is the variable one. Whatever group sits there is what gives each form its name.

That upper ligand is the entire difference between cyanocobalamin and methylcobalamin. The corrin ring, the cobalt, the nucleotide tail - all identical. One has a cyano group. One has a methyl group.

Neither humans nor plants nor animals synthesize cobalamin. Only bacteria and archaea do. Every source of B12 traces back to microbial synthesis, including the industrial supply, which is produced by bacterial fermentation.

The four cobalamin forms

Two of these four are coenzymes, meaning they are the forms that enzymes actually use. Methylcobalamin serves methionine synthase in the cytosol, which remethylates homocysteine to methionine. Adenosylcobalamin serves methylmalonyl-CoA mutase in the mitochondria, which converts methylmalonyl-CoA to succinyl-CoA.

Cyanocobalamin is neither. It is a manufacturing artifact that became the industry default, and understanding why is the point of this post.

What the cyano ligand is, and where it comes from

Bacterial fermentation does not produce cyanocobalamin. It yields a mixture of methyl-, adenosyl-, hydroxo-, and aqua-cobalamins, part of the hydroxo fraction arising during extraction itself. Cyanocobalamin appears during purification: adding cyanide during the extraction step converts the mixed output into a single, uniform compound that crystallizes cleanly.

That is the whole origin story. The cyano group is a purification tool. It binds cobalt tightly, it produces a crystalline red solid that is easy to assay and easy to standardize, and it survives heat, light, and oxidation far better than the coenzyme forms do.

The cyanide question follows naturally and has a quantitative answer. When cyanocobalamin is processed intracellularly, the cyano ligand is released as cyanide ion and cleared. The proportion is small by mass: cyanocobalamin has a molecular weight of roughly 1,355, of which the cyano group accounts for about 26, so the cyanide fraction of the molecule is under 2 percent. That is a statement about stoichiometry, not a safety assessment, and nothing here is medical advice.

Products labeled “B12 injection cyanocobalamin” in pharmacy and compounding settings contain this form for exactly the reasons above: it is the most stable, the most standardized, and the cheapest to produce at scale.

What the methyl ligand is

Methylcobalamin carries a methyl group bound directly to cobalt through a carbon-cobalt bond. That bond is one of very few carbon-metal bonds found in biology, and it is the functional heart of the molecule: methionine synthase works by transferring that methyl group to homocysteine and then reloading it from 5-methyltetrahydrofolate.

The same bond that makes it functional makes it fragile. Carbon-cobalt bonds photolyze - break under light - which is why methylcobalamin requires amber glass, light-protected handling, and shorter stated shelf life. Adenosylcobalamin has the same vulnerability for the same reason.

This is the trade-off in one sentence: the coenzyme forms are reactive because they are supposed to be reactive, and reactive molecules do not sit on shelves well.

How the cell handles both: the step most comparisons skip

The common marketing claim is that methylcobalamin is “already active” and can be used directly, while cyanocobalamin has to be converted first. The second half is true. The first half is not.

Every incoming cobalamin, regardless of upper ligand, goes through the same processing pathway. After transport into the cell and release from its carrier protein in the lysosome, the cobalamin is handed to a cytosolic processing protein encoded by the MMACHC gene. That protein strips the upper ligand by two different reactions: reductive decyanation for cyanocobalamin, and glutathione-dependent dealkylation for the methyl and adenosyl forms. The immediate products differ - cob(II)alamin from decyanation, the highly reducing cob(I)alamin from dealkylation, which readily oxidizes to cob(II)alamin - but both routes converge on the same stripped cobalamin core.

From that common intermediate, the cell builds what it needs. One branch produces methylcobalamin in the cytosol for methionine synthase. The other branch, involving mitochondrial adenosyltransferase, produces adenosylcobalamin for methylmalonyl-CoA mutase.

So methylcobalamin taken in from outside is not routed straight to the enzyme that uses methylcobalamin. It is dealkylated first, then rebuilt. Both forms converge on the same intermediate, and both forms then require the same reconstruction steps.

There is a genuine research question underneath the marketing one - whether the removal step differs measurably in efficiency between ligands, and whether retention and excretion profiles differ between forms. That question is open and studied. It is a different and much narrower claim than “one form is active and the other is not.”

A less commonly discussed member of this family is glutathionylcobalamin, in which glutathione occupies the upper position. It appears in the literature as a proposed intermediate in the intracellular ligand-exchange pathway rather than as a commercial format, and it is a good illustration of how readily that upper position swaps. Glutathione itself is a separate catalog item and is listed on the glutathione product page.

Stability, cost, and shelf life

Read that table as a manufacturing decision rather than a quality ranking. Cyanocobalamin dominates because a supply chain that has to survive transport, warehousing, and time favors the molecule that does not degrade in a lit room. Methylcobalamin costs more per gram because you are paying for the additional synthesis and for handling that protects a photolabile compound.

Either form can be produced at high purity. Either form can also be produced badly. Purity is a function of the manufacturer, not of the ligand.

What the MTHFR discussion is actually about

The People Also Ask box for B12 searches surfaces MTHFR constantly, usually attached to the claim that people with certain variants “cannot convert” cyanocobalamin and therefore require the methyl form. Here is the actual research question, stated neutrally.

MTHFR is methylenetetrahydrofolate reductase, an enzyme in the folate cycle. It converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate. That product is the methyl donor that methionine synthase uses, and methionine synthase is the enzyme that depends on methylcobalamin.

So MTHFR sits adjacent to B12 metabolism, one step upstream in the folate arm of the same reaction. Common variants such as C677T reduce enzyme activity to varying degrees, which is why the gene appears in discussions of homocysteine and one-carbon metabolism at all.

What MTHFR does not do is process the cobalamin upper ligand. That step belongs to a different gene product entirely, the MMACHC processing protein described earlier. The two are separate enzymes acting on separate substrates in separate parts of the pathway.

Whether B12 form makes a measurable difference in people carrying reduced-activity MTHFR variants is a legitimate open research question, and the published evidence on it is limited. It is not the settled fact that the internet framing suggests, and nothing here is a recommendation for any individual. Genotype interpretation is a clinical matter.

Adenosylcobalamin and hydroxocobalamin, briefly

The two forms that get left out of the comparison are worth naming.

Adenosylcobalamin carries a 5′-deoxyadenosyl group and is the mitochondrial coenzyme. It is the dominant storage form in liver tissue. It is sold commercially as cobamamide, mostly outside the US, and shares methylcobalamin’s photosensitivity.

Hydroxocobalamin carries a hydroxyl group and is the main direct output of bacterial fermentation before cyanide is introduced during purification. It is more stable than the two coenzyme forms and less stable than cyanocobalamin. Chemically it is notable for how strongly the cobalt center binds cyanide, which is the property behind its use in a specific clinical setting outside the scope of this post.

A comparison that only names two of the four forms is describing the market, not the chemistry.

Sourcing B12 for research

The practical question for a research buyer is not which ligand is philosophically superior. It is whether the vial contains what the label says at the purity the label claims.

Ask for the Certificate of Analysis and read three things: the identity of the compound including which cobalamin form it is, the purity figure as a number determined by HPLC, and the batch identifier. A COA that states a form the product page does not, or that reports “high purity” instead of a percentage, is not a document you can act on. We wrote a full walkthrough of what a complete document looks like in how to verify a peptide COA, and our own documents are public in the COA library.

Ogni lotto ha una purezza pari o superiore al 99%. Inviateci un certificato di analisi (COA) redatto da un ente indipendente e vi accrediteremo un buono acquisto indipendentemente dai risultati riportati.

WWP ships manufacturer-direct in 10-vial packs. Current catalog and pricing are on the shop page.

Frequently asked questions

Is methylcobalamin better than cyanocobalamin?

They are not ranked forms of one product; they are two molecules that differ by the group attached to cobalt. Both are processed through the same intracellular pathway, which strips the upper ligand before the cell rebuilds the coenzyme it needs. Methylcobalamin occurs naturally and is one of the two coenzyme forms. Cyanocobalamin is more stable, cheaper to manufacture, and easier to standardize, which is why it dominates commercial supply. Which is appropriate for any given purpose depends on that purpose, and WWP makes no recommendation.

Why is cyanocobalamin used in most manufactured products?

Because it survives. The cyano ligand binds cobalt tightly and produces a crystalline compound that tolerates light, heat, and oxidation, giving longer shelf life and simpler assay. The coenzyme forms photolyze and require amber glass and light-protected handling throughout production and storage. The choice is driven by stability and cost, not by activity.

What are the four forms of vitamin B12?

Cyanocobalamin, methylcobalamin, adenosylcobalamin, and hydroxocobalamin. All four share an identical corrin ring with a central cobalt atom and differ only in the group occupying the upper axial position on that cobalt. Methylcobalamin and adenosylcobalamin are the coenzyme forms used by methionine synthase and methylmalonyl-CoA mutase respectively.

Does MTHFR affect which form of B12 the body can process?

MTHFR is an enzyme in the folate cycle, one step upstream of the reaction that uses methylcobalamin. It does not act on the cobalamin ligand itself - that step is handled by a separate gene product. Whether B12 form matters for carriers of reduced-activity MTHFR variants is an open research question with limited published evidence, not an established finding. Genotype interpretation is a clinical matter and outside what this post covers.

Why does glutathione come up alongside B12?

Two reasons, and only one is chemistry. Glutathionylcobalamin, in which glutathione occupies the cobalamin upper position, appears in the literature as a proposed intermediate in intracellular ligand processing. Separately, the two are simply adjacent catalog items that get searched together. They are distinct products with distinct research literatures.

What purity should a B12 COA show?

A number, determined by a stated analytical method, tied to a batch identifier - not an adjective. It should also state which cobalamin form was tested. Every batch WWP ships is ≥99% purity, and the documents are published in the COA library.

The bottom line

The difference between cyanocobalamin and methylcobalamin is one attached group on one cobalt atom, and the consequences of that group are mostly about stability rather than activity. Cyanocobalamin is a purification artifact that turned out to be the most shippable version of the molecule. Methylcobalamin is one of the two forms enzymes actually use, and it is fragile for the same reason it is functional.

Both are stripped down to the same cobalamin core before the cell uses either. That single fact deflates most of the marketing built on this comparison, and it is the part worth remembering.

All products are supplied for laboratory and research use only. Not for human consumption. Nothing in this post is medical advice.